RADISENS DIAGNOSTICS LIMITED

Their core work

Radisens Diagnostics is an Irish SME building integrated point-of-care medical diagnostics platforms, with a specific focus on multi-parameter blood testing for chronic disease management. Their flagship MEDMICO work targeted diabetes and its co-morbidities in a single compact device for primary care settings. They combine microfluidics, assay chemistry and diagnostic data handling, and have recently started engaging with photonics-based pilot manufacturing to industrialise medical device production.

What they specialise in

How they've shifted over time

In 2015-2018 they were in product-build mode, coordinating a EUR 4.5M SME-2 project to develop a diabetes co-morbidity diagnostics platform. From 2020 they moved into a small participant role inside a photonics pilot-manufacturing consortium, suggesting a shift from assay/device R&D toward industrialisation and scale-up. The trajectory reads like a diagnostics SME going from "can we build it?" to "can we manufacture it reliably?".

They appear to be moving from proprietary diagnostic device development into pilot-scale manufacturing and photonics integration, which makes them a useful partner for anyone needing a product-minded diagnostics SME rather than a pure research lab.

How they like to work

Radisens has shown they can coordinate a substantial EUR 4.5M health project, but in their more recent engagement they joined a large photonics consortium as a minor participant. Across two projects they have touched 21 distinct partners in 8 countries, indicating a reasonably open network rather than a fixed loyal circle. Expect a partner who can lead when the project is about their own device, and plug in as a use-case contributor when the project is about someone else's technology platform.

They have worked with 21 unique partners across 8 countries, spanning health and digital/photonics domains. The network is European in scope, with an Irish SME acting as the hub in their own diagnostics project.

What sets them apart

Radisens is unusual among Irish diagnostics SMEs in that they have actually coordinated a multi-million-euro H2020 health project, not just participated in one. They sit at the intersection of diagnostics device engineering and photonics manufacturing, which is a fairly rare combination for an SME. For a consortium builder, they are the kind of partner who brings a concrete device and clinical-adjacent use case rather than a generic SME letter of support.

Highlights from their portfolio

• MEDMICO
  Their flagship project — coordinator role, EUR 4.49M budget, and a clinically ambitious diabetes co-morbidity diagnostics platform.
• MedPhab
  Links their diagnostics work to a European photonics pilot-manufacturing line, signalling a move toward industrial scale-up.